What FeelGood shares with the broader compounded GLP-1 telehealth category is the regulatory context: compounded medications aren't FDA-approved
Buathong S, Leelayoova S, Mungthin M, Naaglor T, Taamasri P, Suwannahitatorn P, Tan-Ariya P
But there are some pretty important reasons, like cost savings, minimizing side effects, preventive benefits, or a combination
In addition, in vitro models of primary human adipose stem cells, researchers detected intracellular fat content and quantitative expression of early and mature adipocyte markers (PPAR, FABP4, and HSL), demonstrating that glucagon can significantly reduce adipocyte differentiation, inhibit adipocyte proliferation and adipogenesis